Leveraging modeling-based bone formation for osteoporosis treatment

利用基于模型的骨形成治疗骨质疏松症

基本信息

  • 批准号:
    10553619
  • 负责人:
  • 金额:
    $ 42.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-05 至 2026-01-31
  • 项目状态:
    未结题

项目摘要

Project Summary The healthy skeleton continuously renews itself throughout the lifespan via closely coupled bone resorption and remodeling-based bone formation. In contrast, modeling-based bone formation, i.e., de novo bone formation without prior activation of bone resorption, is less commonly found in the adult skeleton, but has been identified as an important mechanism by which anabolic agents for osteoporosis, e.g., intermittent parathyroid hormone (PTH) and PTH related peptide (PTHrP), and sclerostin antibody (Scl-Ab), rapidly elicit new bone formation. By developing a novel imaging platform that enables reliable identification of MBF and RBF and subsequent tissue-level mechanical testing in adult rat bone, we discovered that MBF responds faster than RBF to anabolic treatments. Moreover, bone tissue resulting from MBF has a greater resistance to anabolic treatment withdrawal-induced bone loss and increased heterogeneity of elastic modulus compared to pre-existing bone and bone tissue resulting from RBF. These exciting preliminary data provide a strong scientific premise to support our central hypothesis that MBF is a highly efficient regenerative mechanism that leads to sustainable therapeutic benefits on bone tissue quantity and quality, and whole bone strength. Furthermore, our data suggest that, upon early withdrawal from anabolic treatment, ongoing bone formation continues at MBF sites, forming an “anabolic window” that retains the treatment effect; In contrast, the majority of bone tissue formed at RBF sites were resorbed following treatment withdrawal. Therefore, we propose that a cyclic and sequential treatment regimen with alternating anabolic and anti-resorptive treatments will lead to increased mineral deposition and number of MBF, improved retention of bone tissue at RBF and quiescent bone surface, and improved tissue heterogeneity and whole bone strength. The overall objective of this study is to elucidate the cellular mechanisms (Aim 1a) and mechanical consequences (Aim 2a) of MBF and RBF, and to evaluate the new treatment regimen which leverages MBF to improve and extend treatment efficacy (Aim 2a and 2b) using a rat model. By combining our innovative imaging and image analyses with tissue-level mechanical testing approaches, this proposed research project will fill the critical knowledge gap of long-term mechanical consequences of bone tissue formed through MBF and RBF, and provide important insight for the clinical design and optimization of treatment strategies that modulate MBF, a highly efficient but often overlooked regenerative mechanism.
项目摘要 健康的骨骼在整个生命周期中通过紧密结合的骨吸收不断更新自身 和基于重塑的骨形成。相反,基于建模的骨形成,即,新生骨 在没有预先激活骨吸收的情况下形成,在成人骨骼中不太常见,但 被认为是骨质疏松症的合成代谢剂,例如,间歇 甲状旁腺激素(PTH)和PTH相关肽(PTHrP)以及硬化素抗体(Scl-Ab),迅速引起 新骨形成。通过开发一种新的成像平台,能够可靠地识别MBF, RBF和随后的成年大鼠骨组织水平的力学测试,我们发现MBF响应 比RBF更快的合成代谢治疗。此外,由MBF产生的骨组织具有更大的抵抗力, 与对照组相比,合成代谢治疗撤药诱导的骨丢失和弹性模量的异质性增加 由RBF引起的既存骨和骨组织。这些令人兴奋的初步数据提供了一个强有力的 科学前提来支持我们的中心假设,即MBF是一种高效的再生机制, 导致对骨组织数量和质量以及全骨强度的可持续治疗益处。 此外,我们的数据表明,在早期停止合成代谢治疗后, 在MBF部位继续,形成保留治疗效果的“合成代谢窗口”;相反, 在治疗停止后,在RBF部位形成的骨组织被再吸收。因此,我们建议, 交替进行合成代谢和抗吸收治疗的周期性和序贯治疗方案将导致 增加矿物质沉积和MBF数量,改善RBF和静态骨组织保留 骨表面,并改善组织异质性和全骨强度。本研究的总体目标 阐明MBF和RBF的细胞机制(目标1a)和机械后果(目标2a), 并评估利用MBF改善和延长治疗疗效的新治疗方案 (Aim图2a和2b)使用大鼠模型。通过将我们的创新成像和图像分析与组织水平 机械测试方法,这项拟议的研究项目将填补长期的关键知识空白 通过MBF和RBF形成的骨组织的机械后果,并提供重要的见解, 临床设计和优化治疗策略,调节MBF,一个高效,但往往 被忽视的再生机制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiaowei Sherry Liu其他文献

Xiaowei Sherry Liu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiaowei Sherry Liu', 18)}}的其他基金

Influence of sex and sex hormones on modeling- and remodeling-based bone formation
性和性激素对基于建模和重塑的骨形成的影响
  • 批准号:
    10556506
  • 财政年份:
    2022
  • 资助金额:
    $ 42.47万
  • 项目类别:
Leveraging modeling-based bone formation for osteoporosis treatment
利用基于模型的骨形成治疗骨质疏松症
  • 批准号:
    10366040
  • 财政年份:
    2021
  • 资助金额:
    $ 42.47万
  • 项目类别:
Leveraging modeling-based bone formation for osteoporosis treatment
利用基于模型的骨形成治疗骨质疏松症
  • 批准号:
    10208066
  • 财政年份:
    2021
  • 资助金额:
    $ 42.47万
  • 项目类别:
CAREER: Temporal Changes In Rat Maternal Bone During Lactation And After Weaning
职业:哺乳期和断奶后大鼠母骨的时间变化
  • 批准号:
    1653216
  • 财政年份:
    2017
  • 资助金额:
    $ 42.47万
  • 项目类别:
    Standard Grant
Effects of reproduction and lactation on postmenopausal bone health.
生殖和哺乳对绝经后骨骼健康的影响。
  • 批准号:
    9923534
  • 财政年份:
    2017
  • 资助金额:
    $ 42.47万
  • 项目类别:
Effects of reproduction and lactation on postmenopausal bone health.
生殖和哺乳对绝经后骨骼健康的影响。
  • 批准号:
    9309401
  • 财政年份:
    2017
  • 资助金额:
    $ 42.47万
  • 项目类别:
Roles of Modeling- and Remodeling-based Bone Formation in Determining Trabecular Bone Mechanics at Multiple Length Scales
基于建模和重塑的骨形成在确定多个长度尺度的小梁骨力学中的作用
  • 批准号:
    1661858
  • 财政年份:
    2017
  • 资助金额:
    $ 42.47万
  • 项目类别:
    Standard Grant
Micro-CT Imaging Core
Micro-CT 成像核心
  • 批准号:
    10475073
  • 财政年份:
    2016
  • 资助金额:
    $ 42.47万
  • 项目类别:
Micro-CT Imaging Core
Micro-CT 成像核心
  • 批准号:
    10667525
  • 财政年份:
    2016
  • 资助金额:
    $ 42.47万
  • 项目类别:
Micro-CT Imaging Core
Micro-CT 成像核心
  • 批准号:
    10691576
  • 财政年份:
    2016
  • 资助金额:
    $ 42.47万
  • 项目类别:

相似海外基金

The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
  • 批准号:
    10404415
  • 财政年份:
    2023
  • 资助金额:
    $ 42.47万
  • 项目类别:
Characterisation of skeletal development and the use of anabolic agents in murine models of Duchenne muscular dystrophy
杜氏肌营养不良症小鼠模型中骨骼发育的特征和合成代谢药物的使用
  • 批准号:
    MR/N020588/1
  • 财政年份:
    2016
  • 资助金额:
    $ 42.47万
  • 项目类别:
    Fellowship
Application of effect of low-magnitude and high-frequency loading and bone anabolic agents on peri-implant bone in a osteoporosis model
低强度高频负荷和骨合成代谢药物对种植体周围骨的影响在骨质疏松模型中的应用
  • 批准号:
    15K11148
  • 财政年份:
    2015
  • 资助金额:
    $ 42.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7952148
  • 财政年份:
    2009
  • 资助金额:
    $ 42.47万
  • 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7719180
  • 财政年份:
    2008
  • 资助金额:
    $ 42.47万
  • 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7605400
  • 财政年份:
    2007
  • 资助金额:
    $ 42.47万
  • 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7378734
  • 财政年份:
    2006
  • 资助金额:
    $ 42.47万
  • 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7202590
  • 财政年份:
    2005
  • 资助金额:
    $ 42.47万
  • 项目类别:
BONE TARGETED DELIVERY OF ANABOLIC AGENTS
合成代谢药物的骨靶向输送
  • 批准号:
    6824532
  • 财政年份:
    2004
  • 资助金额:
    $ 42.47万
  • 项目类别:
BONE TARGETED DELIVERY OF ANABOLIC AGENTS
合成代谢药物的骨靶向输送
  • 批准号:
    7663959
  • 财政年份:
    2004
  • 资助金额:
    $ 42.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了